The ICO is a comprehensive cancer centre, and as such it fights the disease through all its areas of action, among which is research. Research features as part of the primordial objective of the ICO, as stated in its founding Articles of Association. One of the objectives of research is to bring its results into contact with healthcare in order to improve the quality of life and aid in the survival of patients.
According to the ASCO (American Society of Clinical Oncology), the progress made in cancer treatment over the last 40 years has been the product of investment in research, which has increased significantly the survival rate and brought about a revolution in biological knowledge of the disease, as well as on how to prevent, diagnose and treat it.
The ICO was founded in 1996, and in these 15 years it has become a centre of reference in Catalonia, both in healthcare quality (satisfaction survey results and the 2010 award for Best Clinical Practices from the National Health System, among others) and in research (the top Spanish hospital centre in terms of scientific quality, according to a SCImago independent international report, published recently).
The ICO carries out research in all areas of cancer, from understanding why it develops and how to prevent it, to finding early diagnosis strategies or new, more efficient treatments, as well as research related to caring for end-of-life patients. It also carries out research in nursing, psycho-oncology and social work.
General Management: Candela Calle
Board of Science: Josep Ramon Germà
Translational Research: Ramon Salazar
Clinical Research: Margarita García
ICO Biobank: Berta Laquente
Research Support Office: Núria Benítez
RSO: Research Support Office
V and C: Virus and Cancer
CPC: Cancer Prevention and Control
HC: Hereditary Cancer
TRL: Translational Research Laboratory
LMOS: Molecular Biology Laboratory of the Medical Oncology Service (Badalona)
LHem: Cytogenetics and Molecular Biology Laboratory of the Clinical Haematology Service (Badalona)
CRU: Clinical Research Unit
The ICO has a variety of crosscutting programmes that carry out research, among other things:
Epidemiology of cancer: population studies on the factors that increase the risk of suffering from a cancer.
Prevention: research on the impact of the different measures that can be taken to prevent cancer or detect it early on.
Hereditary cancer: new genes involved in hereditary predisposition to cancer are identified and new strategies are developed to personalise patient monitoring and to assess the emotional impact of genetic counselling.
QUALY Observatory – WHOCC: development of projects aimed at assessing and improving the quality of palliative care, taking into account aspects such as epidemiology, effectiveness and efficiency and satisfaction over the healthcare models developed, in order to generate evidence on the interventions and knowledge that is adaptable and transferable among different organisational models.